CHU Louis Mourier Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT04012138
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Department of visceral and digestive surgery, Louis-Mourier hospital, APHP | Laboratoire de Biochimie, CHU Louis Mourier | Louis Mourier Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

albuterol (proventil) (1 trial)

insulin aspart (Novolog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperkalemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2